Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://ir.novavax.com/press-releases/Novavax-to-Supply-Updated-COVID-19-Vaccine-to-Private-Healthcare-Providers-in-the-United-...
In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, e...
Shah Capital, which owns approximately 6.7% of the outstanding common stock of Novavax, recommends the appointment to Novavax b...
Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will showcase conti...
